Vomaris Releases New Retrospective Study Conclusions
Procellera®’s Microcurrent Technology Associated With Significantly Reduced Healing Times Compared to other Advanced Wound Care Modalities According to a new retrospective study published in the Journal of the American College of Clinical Wound Specialists,1 the use of Procellera Antimicrobial Wound Dressing with its patented microcurrent technology was associated with significantly reduced healing times compared to […]
Breakthrough Microcurrent Technology Product Procellera® Featured in Eight Scientific and Clinical Abstracts at SAWC May 2-5
Vomaris Innovations, Inc., a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced that eight scientific and clinical abstracts on its flagship product Procellera will be presented at the 26th Annual Symposium on Advanced Wound Care (SAWC) May 2 – 5, 2013 at the Denver Convention Center. Procellera […]
Procellera® From Vomaris Innovations Announced as Official Wound Care Sponsor of the Challenged Athletes Foundation
Vomaris Wound Care, Inc. and the Challenged Athletes Foundation (CAF) announced that Procellera, from Vomaris Innovations will serve as the official wound care sponsor of the CAF Elite Paratriathlon Team. The team will use Procellera for minor cuts, scrapes, blisters and abrasions that often occur during training and races. “We are thrilled to provide the […]
Vomaris Announces Initiation of Study with Walter Reed National Military Medical Center’s Combat Wound Initiative
Vomaris Innovations, Inc., a leading edge regenerative medicine company focusing on wound care with bioelectric technology, is pleased to announce the initiation of a new study with Walter Reed National Military Medical Center. The objective of the study, funded by the Henry M. Jackson Foundation for the Advancement of Military Medicine, is the assessment of […]
Vomaris Patent Estate Expands
VOMARIS PATENT ESTATE GROWS TO SIX ISSUED U.S. PATENTS AND THREE GRANTED INTERNATIONAL PATENTS WITH U.S. PAT. NO. 8,224,439 Vomaris Innovations, Inc, a leading regenerative medicine company focusing on wound care with bioelectric technology, has been granted another patent (U.S. Pat. No. 8,224,439) related to its bioelectric technology surrounding the use of devices that rely […]
Vomaris Innovations, Inc. Names New CEO
Vomaris Innovations, Inc, a leading regenerative medicine company focusing on wound care with bioelectric technology, has named Michael P. Nagel as its new President and Chief Executive Officer. Mr. Nagel will also join Vomaris Innovations, Inc.’s Board of Directors. Mr. Nagel brings more than 26 years of sales, marketing and management experience in the medical […]